High Vista Strategies LLC Harrow Health, Inc. Transaction History

High Vista Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.5 - $12.0 $120,793 - $170,532	-14,211 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.99 - $10.6 $27,337 - $41,456	3,911 Added 37.97%	14,211 $129,000
Q1 2020 May 15, 2020	SELL	$3.5 - $7.31 $5,950 - $12,427	-1,700 Reduced 14.17%	10,300 $39,000
Q4 2019 Feb 14, 2020	BUY	$4.6 - $7.88 $55,199 - $94,560	12,000 New	12,000 $93,000

185

21.1M

679K

1.27M

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $769M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.